Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Hypothyroidism Article
This is a selection made from among articles on Drug Treatment Hypothyroidism. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
The Importance of Alcohol Rehab Centers
By Paul S. Allen
Alcohol dependency affects over 15 million Americans, with a shocking half a million of those between the ages of 9 and 12. Alcohol and alcohol related problems contribute to at least $100 million in annual health care costs and loss of productivity. Nearly a quarter of those admitted to hospitals have some type of alcohol problem or are diagnosed for alcohol related consequences. With the statistics at crisis levels, it's important to examine the role that alcohol rehab centers can play in solving these problems.
There are three main approaches to alcohol rehabilitation: Behavioral therapies, 12-step programs, and pharmacological treatment. Most inpatient rehab centers employ a combination of approaches to provide more comprehensive treatment.
Alcoholics Anonymous is the most well-known 12-step program. Most treatment programs, whether outpatient or inpatient, encourage patients to attend one of these self help groups. Some even offer 12-step meetings within their facilities or educate the patient about the program in a learning environment. Behavioral therapies are designed to prevent relapse by teaching the skills necessary to avoid temptation and function normally once their initial treatment is complete. Pharmacological treatment includes the use of medications such as disulfiram and naltrexone to combat the physical symptoms and urges of alcohol dependency.
In 1999, more than 700,000 people received treatment for alcohol each day. A vast majority of them were treated in outpatient facilities. The more intense type of this treatment involves the patient visiting a hospital treatment program for several hours a day on several days a week. The less intensive form of outpatient treatment focuses on counseling sessions once or twice a week, sometimes involving group sessions and family therapy as well as individual counseling.
The advantages of outpatient treatment include lower treatment costs, shorter treatment programs, and the ability to maintain outside relationships and activities while undergoing treatment.
Inpatient alcohol rehab traditionally lasts for 28 days. However, with rising health care costs, this number is diminishing. Studies in the mid 1990s found that inpatient treatment is especially helpful for patients with additional medical and/or psychiatric conditions (also known as dual-diagnosis patients) or for those whose environments are not supportive of rehabilitation.
In addition to the 28 day rehabilitation program, some alcohol rehab centers offer extended stay treatments. These programs allow a patient to enter a therapeutic community for six to twelve months, providing the time necessary for both detoxification and counseling as well as social and occupational therapies that can help them function better once they return to society. These programs are ideal for patients with longer histories of addiction, impaired social functioning, or involvement in serious criminal activities. Alcohol rehab programs that treat adolescents and children also provide for continuing education, such as high school and college courses during the inpatient stay. The longer treatment plan allows for the slow re-socialization of patients to a drug-free and crime-free life.
One of the cornerstones of successful alcohol rehab is detoxification. The symptoms associated with cessation of alcohol consumption are collectively referred to as alcohol withdrawal syndrome. These can include insomnia, irritability, tremors, seizures, delirium tremens, and hallucinations. As a result of the dangers of these sometimes life-threatening symptoms, many alcohol rehab programs require an initial period of detoxification. Even if an alcoholic will be getting outpatient treatment, they may require inpatient detox first. However, there are some detox programs that are administers on an outpatient basis, when the alcohol withdrawal syndrome is less severe.
A successful alcohol rehab center will have a trained, professional staff that ensures quality individual support of patients while maintaining an alcohol and drug-free environment. It will provide comprehensive counseling, education, and referrals to community resources for continuing recovery after treatment. It will offer alcohol and drug education to its patients while conducting outreach to reduce the stigma of addiction and alcoholism in its surrounding community. Most importantly, a quality alcohol rehab center will have a documented record of success rate in rehabilitating patients and the ability to demonstrate the longevity of their patient recovery.
The ultimate goal of alcohol rehabilitation is a productive and sober life for the alcoholic once they complete treatment. The ability of a rehab program to provide the addict with treatment and usable skills to help them abstain from alcohol (or to consume in controlled moderation) is their true measure of success.
Gatehouse Academy is a long term, residential drug and alcohol rehab center exclusively for young adults age 17 - 25. Residents learn life skills, attend therapy, continue formalized education, enhance physical well-being, and recover from the effects of alcohol & drug abuse through focused 12 Step Recovery. For more information on Gatehouse Academy call toll free @ (888) 966-4800
Article Source: http://EzineArticles.com/?expert=Paul_S._Allen
http://EzineArticles.com/?The-Importance-of-Alcohol-Rehab-Centers&id=946262
Drug Treatment Hypothyroidism Specific links
Drug Treatment Hypothyroidism News
Women more prone to hypothyroidism
SHARJAH — Hypothyroidism is a common disorder of thyroid gland. Women are more often affected than men. Thyroid glands are located in neck and produces thyroid hormones which control body metabolism. Metabolism includes things like basal metabolic rate, gut motility, heart rate etc.
Read more...Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line ...
Pfizer announced today that the Committee for Human Medicinal Products of the European Medicines Agency has adopted a positive opinion regarding the marketing authoriz
Read more...Pfizers Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line ...
Pfizer announced today that the Committee for Human Medicinal Products ...
Read more...Press Release
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
Read more...Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories, including tumors of the kidney, lung and hematologic malignancies, at the Annual Meeting of the American Society of Clinical Oncology in Chicago, IL, from June 1-5.
Read more...Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell ...
Pfizer Inc announced today that the Phase 3 INTORSECT study, evaluating TORISEL® in patients with advanced renal cell carcinoma whose disease had progressed on or after SUTENT® therapy, did not meet the primary endpoint of prolonging progression free survival when compared to sorafenib.
Read more...Bestellen Sie den kostenlosen Newsletter von 4investors:
Novartis International AG / Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly . Processed and transmitted by Thomson Reuters ONE.
Read more...MS symptoms 'eased' by pregnancy
Researchers are carrying out clinical trials to find out if women with autoimmune diseases could be helped by hormones found in pregnancy.
Read more...Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients ...
Novartis International AG / Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible …
Read more...Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic ...
RARITAN, N.J., May 17, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release tablets were ...
Read more...